Joey P Granger Selected Research

Joey P Granger Research Topics

Disease

59	Hypertension (High Blood Pressure) 06/2021 - 02/2002
49	Pre-Eclampsia (Preeclampsia) 01/2022 - 02/2002
45	Ischemia 06/2021 - 02/2002
8	Obesity 03/2017 - 09/2013
7	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 10/2021 - 02/2002
7	Hypoxia (Hypoxemia) 09/2017 - 07/2002
5	Body Weight (Weight, Body) 01/2019 - 10/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 11/2005
2	Fibrosis (Cirrhosis) 01/2020 - 06/2011
2	Edema (Dropsy) 01/2018 - 04/2016
1	Hypertrophy 01/2020
1	Neuroinflammatory Diseases 01/2018
1	Albuminuria 01/2017
1	Hyperphagia (Overeating) 10/2016
1	Inflammation (Inflammations) 10/2016
1	Fetal Weight 12/2014
1	Weight Loss (Weight Reduction) 01/2014
1	Hyperinsulinism (Hyperinsulinemia) 12/2013
1	Gilbert Disease 01/2012

Drug/Important Bio-Agent (IBA)

22	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 02/2002
20	Endothelins (Endothelin)IBA 10/2018 - 07/2002
19	CytokinesIBA 01/2022 - 02/2002
10	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2012 - 07/2002
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 02/2002
9	Endothelin-1 (Endothelin 1)IBA 01/2018 - 02/2010
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2016 - 12/2007
8	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2019 - 02/2010
8	Heme Oxygenase-1IBA 01/2018 - 02/2009
8	Tyrosine (L-Tyrosine)FDA Link 04/2016 - 12/2007
5	salicylhydroxamic acid (SHAM)IBA 01/2021 - 12/2014
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2002
5	Angiotensin IIIBA 12/2019 - 07/2002
5	Superoxides (Superoxide)IBA 04/2016 - 07/2002
5	SaltsIBA 10/2012 - 02/2002
4	LeptinIBA 01/2021 - 05/2015
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 12/2007
4	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 01/2019 - 09/2013
4	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 01/2018 - 03/2013
4	BilirubinIBA 01/2018 - 09/2009
4	Carbon MonoxideIBA 10/2017 - 11/2011
4	AutoantibodiesIBA 02/2017 - 12/2008
3	activin AIBA 01/2022 - 01/2020
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2021 - 11/2016
3	AngiotensinsIBA 12/2019 - 12/2008
3	tempolIBA 04/2016 - 10/2008
3	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2016 - 11/2005
3	Sildenafil Citrate (Viagra)FDA Link 03/2016 - 11/2005
3	Etanercept (Enbrel)FDA Link 12/2015 - 06/2011
3	Interleukin-6 (Interleukin 6)IBA 11/2015 - 10/2006
2	Interleukin-17 (Interleukin 17)IBA 06/2021 - 11/2015
2	Type 1 Angiotensin ReceptorIBA 02/2017 - 11/2015
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 04/2016 - 11/2015
2	AntioxidantsIBA 04/2016 - 10/2008
2	Pharmaceutical PreparationsIBA 01/2016 - 03/2013
2	Insulin (Novolin)FDA Link 12/2015 - 12/2013
2	EnzymesIBA 01/2012 - 04/2003
2	Messenger RNA (mRNA)IBA 06/2011 - 09/2004
2	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 01/2011 - 03/2004
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2010 - 05/2009
2	EndoglinIBA 08/2010 - 02/2009
2	NitritesIBA 10/2009 - 09/2009
2	hexanoic acid (hexanoate)IBA 10/2009 - 09/2009
2	NitratesIBA 10/2009 - 09/2009
2	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 10/2009 - 09/2009
2	Vasodilator Agents (Vasodilators)IBA 02/2008 - 07/2002
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 02/2008 - 07/2002
1	Degenerin Sodium ChannelsIBA 01/2022
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021
1	Activins (Activin)IBA 01/2021
1	FollistatinIBA 01/2021
1	AdipokinesIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2018
1	OccludinIBA 01/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2018
1	Hemeproteins (Heme Protein)IBA 09/2017
1	fluorescein-isothiocyanate sinistrinIBA 01/2017
1	N-formyl-13-dihydrocarminomycin (NFD)IBA 10/2016
1	LigandsIBA 04/2016
1	Glucose (Dextrose)FDA LinkGeneric 12/2015
1	LipidsIBA 12/2015
1	Phosphotransferases (Kinase)IBA 12/2014
1	Heme (Haem)IBA 10/2014
1	OxygenasesIBA 10/2014
1	MineralocorticoidsIBA 10/2014
1	Ouabain (G Strophanthin)IBA 10/2014
1	Matrix Metalloproteinase InhibitorsIBA 03/2013
1	Matrix Metalloproteinases (MMPs)IBA 03/2013
1	AldosteroneIBA 10/2012
1	ReninIBA 10/2012
1	Antihypertensive Agents (Antihypertensives)IBA 10/2012
1	Natriuretic AgentsIBA 10/2012
1	Vasoconstrictor AgentsIBA 09/2011
1	Endothelin A ReceptorIBA 09/2011
1	SodiumIBA 08/2011
1	Oxygen (Dioxygen)IBA 08/2011
1	Angiogenic ProteinsIBA 08/2011

Therapy/Procedure

6	Therapeutics 01/2020 - 08/2011
1	Respiratory Therapy (Therapy, Respiratory) 01/2014